Literature DB >> 2759109

Quality of life five years after myocardial infarction.

I Wiklund1, J Herlitz, A Hjalmarson.   

Abstract

In 539 patients 5 years after myocardial infarction (MI), quality of life and factors influencing life quality were studied. All patients originally participated in an early intervention trial with metoprolol. A cardiac follow-up questionnaire and the Nottingham Health Profile were answered by 82%. In the former, information about subjective symptoms, smoking, work and current medication was obtained; the latter described health-related quality of life in terms of energy, sleep, emotions, mobility, pain and social isolation. The rate of and the reasons for rehospitalization were registered in the patients' records. The MI patients reported a comparatively high quality of life. Compared with 'normal' population, a decrease was noted in energy, sleep and mobility, and in sex life, hobby-activity and holiday activity. A nonparametric multivariate analysis disclosed that dyspnoea, angina pectoris and anxiety were closely associated with decreased quality of life. In conclusion, 5 years after MI most patients seemed well-adjusted. Impaired quality of life was reported by patients suffering from angina pectoris, dyspnoea and emotional distress. No relationship was found between health-related quality of life and the beta blocker, metoprolol, which was the most frequently used drug.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2759109     DOI: 10.1093/oxfordjournals.eurheartj.a059511

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  14 in total

1.  Persistent impaired emotional functioning in survivors of a myocardial infarction?

Authors:  C M Plevier; J M Mooy; P J Marang-Van de Mheen; M E Stouthard; M C Visser; D E Grobbee; L J Gunning-Schepers
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  An improved questionnaire for assessing quality of life after acute myocardial infarction.

Authors:  L Valenti; L Lim; R F Heller; J Knapp
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

Review 3.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

4.  State anxiety predicts poor psychosocial outcome after coronary bypass surgery.

Authors:  G Grossi; A Perski; E Feleke; U Jakobson
Journal:  Int J Behav Med       Date:  1998

5.  Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population.

Authors:  N Brown; M Melville; D Gray; T Young; J Munro; A M Skene; J R Hampton
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

6.  Dyspnea Among Patients With Chronic Total Occlusions Undergoing Percutaneous Coronary Intervention: Prevalence and Predictors of Improvement.

Authors:  Mohammed Qintar; J Aaron Grantham; James Sapontis; Kensey L Gosch; William Lombardi; Dimitri Karmpaliotis; Jeffery Moses; Adam C Salisbury; David J Cohen; John A Spertus; Suzanne V Arnold
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-12

7.  Prognostic Value of Serial N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients With Acute Myocardial Infarction.

Authors:  Michael C Kontos; David E Lanfear; Kensey Gosch; Stacie L Daugherty; Paul Heidenriech; John A Spertus
Journal:  Am J Cardiol       Date:  2017-04-27       Impact factor: 2.778

8.  Health related quality of life after conservative or invasive treatment of inducible postinfarction ischaemia. DANAMI study group.

Authors:  O S Mortensen; J K Madsen; T Haghfelt; P Grande; K Saunamäki; S Haunsø; E Hjelms; H Arendrup
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

9.  Limited long term effects of a management programme for heart failure.

Authors:  M Mejhert; T Kahan; H Persson; M Edner
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

10.  Methods for assessing quality of life in the cardiac arrhythmia suppression trial (CAST).

Authors:  I Willund; L Gorkin; Y Pawitan; E Schron; J Schoenberger; L L Jared; S Shumaker
Journal:  Qual Life Res       Date:  1992-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.